Position in NAUT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$21,755,974
-$27,109,564 QoQ
Shares Held
11,634,211
-7.6% QoQ
Ownership
9.16%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#1
of 93 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAUT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PERCEPTIVE ADVISORS LLC holds $5,486,611,234 across 68 Biotechnology names. NAUT ranks #40 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
2,035,986 | $681,627,752 | |
| 2 | SYRE |
Spyre Therapeutics, Inc.
|
4,319,496 | $383,484,854 | |
| 3 | CELC |
Celcuity Inc.
|
3,197,200 | $334,491,064 | |
| 4 | ASND |
Ascendis Pharma A/S
|
1,163,721 | $310,387,665 | |
| 5 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,586,295 | $287,156,333 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
8,085,461 | $286,144,464 | |
| 7 | RLAY |
Relay Therapeutics, Inc.
|
14,106,187 | $263,926,758 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
3,752,574 | $213,183,728 |
All Filings in NAUT
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,755,974 | 11,634,211 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $21,755,974 | 11,634,211 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $48,865,538 | 12,594,211 | Shares | Sole | 2026-05-29 | |
| 2025-12-31 | $24,558,711 | 12,594,211 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,642,108 | 12,594,211 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,130,802 | 12,594,211 | Shares | Sole | 2025-08-14 | |
| 2025-06-20 | $9,162,805 | 12,815,113 | Shares | Sole | 2025-06-24 | |
| 2025-03-31 | $10,843,615 | 12,594,211 | Shares | Sole | 2025-08-06 | |
| 2025-01-31 | $21,536,100 | 12,594,211 | Shares | Sole | 2025-01-31 | |
| 2024-12-31 | $21,158,274 | 12,594,211 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $35,893,501 | 12,594,211 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $29,470,453 | 12,594,211 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $37,026,980 | 12,594,211 | Shares | Sole | 2024-08-06 | |
| 2023-12-31 | $37,656,690 | 12,594,211 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $28,791,237 | 9,111,151 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $35,260,154 | 9,111,151 | Shares | Sole | 2023-08-24 | |
| 2023-03-31 | $25,237,888 | 9,111,151 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $16,400,071 | 9,111,151 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $19,315,640 | 9,111,151 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $24,508,996 | 9,111,151 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $39,542,395 | 9,111,151 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $47,195,762 | 9,111,151 | Shares | Sole | 2022-04-13 | |
| 2021-09-30 | $54,714,467 | 8,911,151 | Shares | Sole | 2021-12-03 | |
| 2021-06-30 | $90,002,625 | 8,911,151 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||